Learn the potentials of each preclinical asset, and predict the level of certainty for each strategic option. Today’s technological molecules require innovation in the development process. We cannot keep using yesterday’s assumptions for tomorrow’s drugs. Marketed product evidence proves that identical molecules developed by different sponsors generated very different drug opportunities. Data show that options’ […]